http://www.diva-portal.org
Preprint
This is the submitted version of a paper published in Journal of Nuclear Medicine.
Citation for the original published paper (version of record):
Eriksson, J., Roy, T., Sawadjoon, S., Bachmann, K., Sköld, C. et al. [Year unknown!]
Synthesis and preclinical evaluation of the CRTH2 antagonist [
11C]MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass
Journal of Nuclear Medicine
Access to the published version may require subscription.
N.B. When citing this work, cite the original published paper.
Permanent link to this version:
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-381559
Synthesis and preclinical evaluation of the CRTH2 antagonist [ 11 C]MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass
Jonas Eriksson a* , Tamal Roy a , Supaporn Sawadjoon a , Kim Bachmann a , Christian Sköld a , Mats Larhed b , Jan Weis c , Ram Kumar Selvaraju a , Olle Korsgren d , Olof Eriksson b , Luke R. Odell a*
a
Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden
b
Department of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
c
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
d